BioLife SolutionsBLFS
Market Cap: $1.1B
About: BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
Employees: 414
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
1,876% more call options, than puts
Call options by funds: $336K | Put options by funds: $17K
114% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 14
100% more funds holding in top 10
Funds holding in top 10: 2 [Q1] → 4 (+2) [Q2]
21% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 48
21% more capital invested
Capital invested by funds: $827M [Q1] → $997M (+$170M) [Q2]
11% more funds holding
Funds holding: 148 [Q1] → 164 (+16) [Q2]
2.57% more ownership
Funds ownership: 98.52% [Q1] → 101.08% (+2.57%) [Q2]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
Craig-Hallum Matt Hewitt 18% 1-year accuracy 2 / 11 met price target | 26%upside $30 | Buy Maintained | 12 Aug 2024 |
Northland Capital Markets Carl Byrnes 50% 1-year accuracy 2 / 4 met price target | 18%upside $28 | Outperform Maintained | 9 Aug 2024 |
TD Cowen Steven Mah 25% 1-year accuracy 1 / 4 met price target | 9%upside $26 | Buy Maintained | 17 Jul 2024 |
Financial journalist opinion
Based on 4 articles about BLFS published over the past 30 days